本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aligos Therapeutics, Inc.

5.29
-0.4450-7.76%
盘后5.26-0.0300-0.57%19:57 EDT
成交量:16.25万
成交额:87.11万
市值:3,234.73万
市盈率:-0.31
高:5.58
开:5.58
低:5.12
收:5.74
数据加载中...
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/06

重要事件披露

8-K - Current report
2021/11/18

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/11/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/24

重要事件披露

8-K - Current report
2021/06/24

重要事件披露

8-K/A [Amend] - Current report
2021/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership